28 Day infected vs. control
Gene
Symbol
Control Avg.Ct ± SEM Infected Avg.Ct ± SEM FoldChange p-value Gene
Symbol
Control Avg.Ct ± SEM Infected Avg.Ct ± SEM Fold
Change
p‐value
Ccl1 13.84 ± 0.32 12.03 ± 0.32 3.5 0.04 Il16 7.41 ± 0.17 6.24 ± 0.27 2.2 0.045
Ccl17 9.56 ± 0.11 7.76 ± 0.21 3.5 0.009 Il27 11.83 ± 0.11 9.70 ± 0.15 4.4 0.002
Ccl2 7.31 ± 0.29 4.53 ± 0.35 6.8 0.025 Lta 11.01 ± 0.21 9.01 ± 0.37 4 0.037
Ccl22 9.18 ± 0.13 7.45 ± 0.31 3.3 0.025 Ltb 6.85 ± 0.16 3.58 ± 0.29 9.6 0.009
Ccl24 11.64 ± 0.13 12.81 ± 0.30 0.4 0.018 Tgfb2 0.67 ± 0.04 2.57 ± 0.76 0.3 0.03
Ccl3 11.52 ± 0.34 8.49 ± 0.13 8.2 0.001 Tnf 9.77 ± 0.22 6.93 ± 0.30 7.2 0.013
Ccl4 9.73 ± 0.39 6.41 ± 0.15 10 0.001 Tnfsf11 10.44 ± 0.47 8.68 ± 0.28 3.4 0.029
Ccl5 5.80 ± 0.05 1.75 ± 0.27 16.6 0.008 Xcl1 7.00 ± 0.19 5.29 ± 0.23 3.3 0.016
Cd40lg 14.40 ± 0.61 8.19 ± 0.35 74 0.016 Ccl12 7.01 ± 0.25 3.70 ± 0.30 9.9 0.015
Csf2 12.12 ± 0.45 9.31 ± 0.17 7 0.002 Ccl7 6.68 ± 0.33 3.63 ± 0.36 8.3 0.027
Cxcl10 8.91 ± 0.06 4.99 ± 0.31 15.1 0.012 Cxcl5 10.50 ± 0.10 5.42 ± 0.46 34 0.049
Cxcl13 7.80 ± 0.73 4.10 ± 0.13 13 0.001 Gusb 2.88 ± 0.09 2.27 ± 0.15 1.5 0.035
Cxcl16 5.19 ± 0.15 3.27 ± 0.20 3.8 0.008 Il12a 12.98 ± 0.35 11.79 ± 0.26 2.3 0.045
Cxcl9 8.26 ± 0.21 2.47 ± 0.18 55.3 0.001 Il18 6.87 ± 0.06 5.92 ± 0.11 1.9 0.003
Fasl 10.13 ± 0.21 6.46 ± 0.20 12.8 0.002 Il1b 8.29 ± 0.52 5.55 ± 0.33 6.7 0.023
Ifna2 11.25 ± 0.08 12.23 ± 0.38 0.5 0.041 Osm 10.42 ± 0.13 8.05 ± 0.13 5.2 0.001
Ifng 11.30 ± 0.08 7.21 ± 0.28 17.1 0.006 Tnfsf10 5.96 ± 0.13 4.12 ± 0.29 3.6 0.02
Il12b 10.68 ± 0.24 8.07 ± 0.26 6.1 0.007          
Table 2: Effect of treatment on the expression of mRNAs in the uterus at 28 days post‐infection.